The effect of bisphosphonates and titanium particles on osteoblasts: an in vitro study

Détails

ID Serval
serval:BIB_02B7AE397FCF
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
The effect of bisphosphonates and titanium particles on osteoblasts: an in vitro study
Périodique
Journal of Bone and Joint Surgery. British Volume
Auteur(s)
Peter  B., Zambelli  P. Y., Guicheux  J., Pioletti  D. P.
ISSN
0301-620X (Print)
Statut éditorial
Publié
Date de publication
08/2005
Volume
87
Numéro
8
Pages
1157-63
Notes
Journal Article --- Old month value: Aug
Résumé
In an attempt to increase the life of cementless prostheses, an hydroxyapatite-coated implant which releases a bisphosphonate has been suggested as a drug-delivery system. Our in vitro study was designed to determine the maximum dose to which osteoblasts could be safely exposed.Our findings demonstrated that zoledronate did not impair the proliferation of human osteoblasts when used at concentrations below 1 microm. Murine cells can be exposed to concentrations as high as 10 microm.A concentration of 0.01% of titanium particles did not impair the proliferation of either cell line. Zoledronate affected the alkaline phosphatase activity of murine osteoblasts through a chelation phenomenon. The presence of titanium particles strongly decreased the alkaline phosphatase activity of murine osteoblasts. We did not detect any synergic effect of zoledronate and titanium particles on the behaviour of both human and murine osteoblasts.
Mots-clé
Alkaline Phosphatase/drug effects/metabolism Animals Cell Division/drug effects Cells, Cultured Coated Materials, Biocompatible Diphosphonates/*toxicity Dose-Response Relationship, Drug Drug Interactions Humans Hydroxyapatites Imidazoles/*toxicity Mice Osteoblasts/cytology/*drug effects/enzymology Titanium/*pharmacology
Pubmed
Web of science
Création de la notice
28/01/2008 12:29
Dernière modification de la notice
20/08/2019 12:24
Données d'usage